+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bio-Pharmaceutical Logistics Market - Global Forecast 2026-2032- Product Image
Bio-Pharmaceutical Logistics Market - Global Forecast 2026-2032- Product Image
Sale

Bio-Pharmaceutical Logistics Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904733
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bio-Pharmaceutical Logistics Market is projected to reach USD 102.56 Billion in 2026. It is expected to continue growing at a CAGR of 12.31%, reaching USD 206.44 Billion by 2032.

Bio-pharmaceutical logistics has become a strategic growth engine for life sciences organizations as biologics, vaccines, cell and gene therapies, clinical trial materials, and specialty medicines require validated temperature control, chain-of-custody visibility, and regulatory-ready documentation. Unlike conventional freight, bio-pharma supply chains must protect product identity, potency, sterility, and patient safety across controlled ambient, refrigerated, frozen, and ultra-low-temperature lanes.

The sector is being shaped by measurable healthcare demand, stricter good distribution practice requirements, and the expansion of high-value therapies. The WHO has consistently emphasized that vaccine quality depends on effective cold-chain management, while regulators such as the U.S. FDA and European authorities continue to elevate expectations around serialization, traceability, quality systems, and data integrity. As a result, pharmaceutical logistics providers are competing on validated cold chain packaging, lane qualification, real-time monitoring, deviation management, and resilient global network design.

Transformative Shifts in the Logistics Landscape

The bio-pharmaceutical logistics landscape is shifting from shipment execution to end-to-end product stewardship. Growth in biologics, biosimilars, GLP-1 therapies, oncology medicines, vaccines, and advanced therapy medicinal products is increasing demand for temperature-controlled warehousing, specialty courier services, cryogenic handling, and direct-to-patient distribution models.

At the same time, supply chain leaders are redesigning networks for resilience after pandemic-era disruption, geopolitical risk, extreme weather, and capacity volatility exposed weaknesses in long, single-source distribution routes. Compliance frameworks such as EU Good Distribution Practice, U.S. Drug Supply Chain Security Act requirements, IATA pharmaceutical handling standards, and national import controls are driving investment in traceability, validated packaging, qualified carriers, quality agreements, and digital control towers.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding gains across bio-pharmaceutical logistics by improving demand forecasting, route optimization, temperature excursion prediction, warehouse labor planning, customs document review, and exception management. When AI models are connected to IoT sensors, GPS telemetry, weather feeds, airline schedules, customs milestones, inventory records, and quality data, logistics teams can move from reactive intervention to predictive risk mitigation.

The strongest use cases are practical and auditable: AI-assisted lane qualification, automated deviation triage, predictive maintenance for cold rooms and refrigerated vehicles, dynamic packaging selection, inventory positioning, and document intelligence for customs and quality release. However, adoption must remain aligned with GxP validation, cybersecurity controls, data integrity principles, explainability, and human oversight because AI recommendations can affect regulated product quality and patient outcomes.

Key Regional Insights

Asia-Pacific is expanding rapidly as China, India, Japan, South Korea, Australia, and ASEAN markets scale biologics manufacturing, clinical trials, vaccine distribution, and specialty medicine access. The region’s diverse geography, rising healthcare investment, and increasing participation in global clinical development are making temperature-controlled pharmaceutical logistics, validated packaging, and import-export compliance central priorities. North America remains a high-value hub due to the United States’ advanced therapy pipeline, DSCSA-driven traceability, strong third-party logistics infrastructure, and Canada’s GDP-aligned cold-chain standards across long-distance healthcare distribution routes.

Europe benefits from harmonized EU GDP expectations, dense cross-border healthcare distribution, established serialization requirements, and mature pharmaceutical manufacturing clusters in Germany, France, Italy, Spain, and the United Kingdom. Latin America is strengthening cold-chain capability around Brazil and Mexico, although infrastructure variability, security considerations, and customs complexity make lane validation critical. The Middle East is becoming a strategic transit and healthcare logistics hub through GCC investments in airports, free zones, and life sciences infrastructure, while Africa’s opportunity is tied to vaccine access, regional cold storage, public health programs, and last-mile reliability improvements supported by international immunization and healthcare supply initiatives.

Key Group Insights

ASEAN is gaining importance as pharmaceutical companies diversify manufacturing and clinical supply chains across Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines, with regional growth supported by healthcare spending, trade connectivity, and improving cold-chain assets. The GCC is positioning itself as a temperature-controlled distribution bridge between Europe, Asia, and Africa, supported by airport cargo capacity, logistics parks, free-zone infrastructure, and national healthcare modernization programs.

The European Union provides one of the most structured regulatory environments for bio-pharmaceutical logistics through GDP guidance, Falsified Medicines Directive serialization, pharmacovigilance expectations, and cross-border market access. BRICS economies are central to long-term demand because they combine large patient populations with expanding domestic pharmaceutical production, public health distribution needs, and growing biologics capabilities. G7 markets remain the innovation and reimbursement anchors for high-value biologics, vaccines, and advanced therapies, while NATO-aligned logistics capabilities can influence resilience planning, emergency preparedness, secure medical supply routes, and contingency logistics for critical healthcare products.

Key Country Insights

The United States leads in specialty logistics complexity due to advanced therapies, specialty pharmacy distribution, decentralized clinical trial models, and FDA DSCSA package-level traceability requirements. Canada emphasizes quality-assured cold-chain distribution across long distances and variable climates, while Mexico is gaining relevance through nearshoring, pharmaceutical manufacturing, and cross-border healthcare logistics. Brazil anchors Latin American demand with a large healthcare system, immunization programs, and growing biologics adoption.

In Europe, the United Kingdom remains a clinical research and specialty distribution hub, Germany combines pharmaceutical manufacturing strength with advanced logistics infrastructure, France maintains strong public health and biopharma capacity, Russia requires careful risk, sanctions, and compliance management, and Italy and Spain support mature pharmaceutical manufacturing and hospital distribution networks. In Asia-Pacific, China and India are critical manufacturing and demand centers with expanding biologics and vaccine capabilities, Japan prioritizes high-quality regulated distribution and precise cold-chain execution, Australia requires robust long-distance cold-chain planning across dispersed population centers, and South Korea is becoming a major biopharma manufacturing and clinical supply market supported by advanced healthcare infrastructure.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize validated cold-chain network design, supplier qualification, quality agreements, and lane-level risk assessment before expanding capacity. Investments in real-time temperature monitoring, reusable and qualified packaging, automated quality documentation, and GDP-compliant warehousing deliver measurable value by reducing excursions, shortening release cycles, improving deviation control, and strengthening audit readiness.

Companies should also establish AI governance, integrate control tower data with quality management systems, and develop contingency routes for customs delays, carrier disruptions, temperature excursions, product recalls, and extreme weather. Strategic partnerships with certified carriers, specialty couriers, airlines, packaging providers, clinical supply specialists, and regional healthcare distributors are essential for scaling global reach without compromising product integrity, regulatory compliance, or patient safety.

Research Methodology

This executive summary is built using a structured research methodology that combines secondary research, regulatory review, market mapping, and expert interpretation. Sources include public guidance from health authorities, GDP and GxP frameworks, customs and trade references, logistics certification programs, healthcare infrastructure indicators, pharmaceutical supply chain standards, and public data on manufacturing, clinical trials, immunization, and healthcare access.

Insights are validated through triangulation across regulatory evidence, operational benchmarks, regional logistics conditions, and demand signals from pharmaceutical manufacturing, clinical development, biologics adoption, specialty medicine distribution, and public health programs. The methodology emphasizes data-backed conclusions, avoids unsupported market claims, and focuses on factors that materially affect bio-pharmaceutical logistics performance, compliance, resilience, and patient-centric delivery.

Conclusion

Bio-pharmaceutical logistics is evolving into a highly specialized discipline where quality assurance, digital visibility, regulatory compliance, and network resilience determine competitive advantage. As medicines become more personalized, temperature-sensitive, high-value, and time-critical, logistics providers and pharmaceutical manufacturers must manage every shipment as a regulated extension of the product lifecycle.

Organizations that combine validated infrastructure, AI-enabled risk management, global compliance expertise, qualified partner ecosystems, and regional execution strength will be best positioned to serve the next generation of biologics, vaccines, clinical trial materials, and advanced therapies. The sector’s direction is clear: patient safety, product integrity, and data-driven logistics excellence will define leadership.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bio-Pharmaceutical Logistics Market, by Product Type
7.1. Introduction
7.2. Biologics
7.3. Blood Products
7.4. Vaccines
8. Bio-Pharmaceutical Logistics Market, by Service Type
8.1. Introduction
8.2. Cold Chain Packaging
8.3. Customs Clearance
8.4. Freight Forwarding
8.5. Storage And Distribution
8.6. Value Added Services
8.6.1. Kitting Services
8.6.2. Labeling Services
8.6.3. Quality Inspection
9. Bio-Pharmaceutical Logistics Market, by Mode Of Transport
9.1. Introduction
9.2. Air
9.3. Rail
9.4. Road
9.5. Sea
10. Bio-Pharmaceutical Logistics Market, by Temperature Requirement
10.1. Introduction
10.2. Ambient
10.3. Cryogenic
10.4. Frozen
10.5. Refrigerated
11. Bio-Pharmaceutical Logistics Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Contract Research Organizations
11.4. Hospitals
11.5. Pharmaceutical Companies
11.6. Research Institutes
12. Bio-Pharmaceutical Logistics Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Bio-Pharmaceutical Logistics Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Bio-Pharmaceutical Logistics Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Agility Public Warehousing Company K.S.C.P.
16.2. Air Canada Cargo Inc.
16.3. Almac Group Limited
16.4. AmerisourceBergen Corporation
16.5. Biocair Limited
16.6. C.H. Robinson Worldwide, Inc.
16.7. Cardinal Health, Inc.
16.8. CEVA Logistics AG
16.9. Cryoport Inc.
16.10. DB Schenker
16.11. DHL Group
16.12. DSV Panalpina A/S
16.13. FedEx Corporation
16.14. GEODIS S.A.
16.15. Kerry Logistics Network Limited
16.16. Kuehne + Nagel International AG
16.17. MNX Global Logistics LLC
16.18. Movianto Group
16.19. Nippon Express Co., Ltd.
16.20. PCI Pharma Services Holdings LLC
16.21. QuickSTAT Global Life Science Logistics Inc.
16.22. SF Express Co., Ltd.
16.23. Thermo Fisher Scientific Inc.
16.24. United Parcel Service, Inc.
16.25. World Courier Inc.
List of Figures
FIGURE 1. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL BLOOD PRODUCTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL BLOOD PRODUCTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL COLD CHAIN PACKAGING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL COLD CHAIN PACKAGING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL COLD CHAIN PACKAGING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL CUSTOMS CLEARANCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL CUSTOMS CLEARANCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL CUSTOMS CLEARANCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL FREIGHT FORWARDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL FREIGHT FORWARDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL FREIGHT FORWARDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL STORAGE AND DISTRIBUTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL STORAGE AND DISTRIBUTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL STORAGE AND DISTRIBUTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL VALUE ADDED SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL VALUE ADDED SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL VALUE ADDED SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL KITTING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL KITTING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL KITTING SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL LABELING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL LABELING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL LABELING SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL QUALITY INSPECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL QUALITY INSPECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL QUALITY INSPECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL AIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL AIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL AIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL RAIL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL RAIL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL RAIL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL ROAD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL ROAD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL ROAD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL SEA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL SEA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL SEA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL AMBIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL AMBIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL AMBIENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL CRYOGENIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL CRYOGENIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL CRYOGENIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL FROZEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL FROZEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL FROZEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL REFRIGERATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL REFRIGERATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL REFRIGERATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 88. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 90. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 91. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 92. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 93. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 94. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 97. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 98. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 99. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 100. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 101. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 102. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 104. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 105. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 106. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 107. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 108. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 109. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 111. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 112. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 113. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 114. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 115. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 116. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 118. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 120. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 121. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 122. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 124. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 126. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 127. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 128. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 129. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 130. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 131. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 133. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 134. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 135. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 136. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 137. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 138. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 140. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 141. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 142. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 143. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 144. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 152. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 154. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 155. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 156. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 157. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 158. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 159. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 160. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 161. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 162. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 163. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 164. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 165. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 166. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 167. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 168. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 169. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 170. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 171. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 172. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 173. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 175. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 176. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 177. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 178. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 179. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 180. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 181. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 182. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 183. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 184. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 185. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 186. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 187. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 188. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 189. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 190. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 191. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 192. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 193. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 194. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 195. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 196. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 197. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 198. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 199. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 200. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 201. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 202. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 203. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 204. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 205. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 206. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 207. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 208. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 209. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 210. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 211. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 212. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 213. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 214. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 215. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 216. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 217. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 218. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 219. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 220. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 221. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 222. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 223. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 224. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 225. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 226. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 227. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 228. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 229. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 230. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 231. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 232. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 233. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 234. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 235. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 236. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 237. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 238. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 239. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 240. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 241. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 242. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 243. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 244. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 245. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 246. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 247. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 248. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 249. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 250. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 251. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 252. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 253. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 254. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 255. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 256. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 257. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 258. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 259. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 260. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 261. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 262. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 263. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 264. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 265. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 266. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 267. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 268. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2017-2032 (USD MILLION)
TABLE 269. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2017-2032 (USD MILLION)
TABLE 270. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2017-2032 (USD MILLION)
TABLE 271. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 272. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 273. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Agility Public Warehousing Company K.S.C.P.
  • Air Canada Cargo Inc.
  • Almac Group Limited
  • AmerisourceBergen Corporation
  • Biocair Limited
  • C.H. Robinson Worldwide, Inc.
  • Cardinal Health, Inc.
  • CEVA Logistics AG
  • Cryoport Inc.
  • DB Schenker
  • DHL Group
  • DSV Panalpina A/S
  • FedEx Corporation
  • GEODIS S.A.
  • Kerry Logistics Network Limited
  • Kuehne + Nagel International AG
  • MNX Global Logistics LLC
  • Movianto Group
  • Nippon Express Co., Ltd.
  • PCI Pharma Services Holdings LLC
  • QuickSTAT Global Life Science Logistics Inc.
  • SF Express Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • United Parcel Service, Inc.
  • World Courier Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 102.56 Billion
Forecasted Market Value ( USD ) by 2032 $ 206.44 Billion
Compound Annual Growth Rate12.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Warehousing in Pharmaceutical Logistics Market - Global Forecast 2026-2032 - Product Image

Warehousing in Pharmaceutical Logistics Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Biopharmaceutical Cold Chain Logistics Services Market - Global Forecast 2026-2032 - Product Image

Biopharmaceutical Cold Chain Logistics Services Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Bulk Liquid Logistics - Global Strategic Business Report - Product Image

Bulk Liquid Logistics - Global Strategic Business Report

  • Report
  • 294 Pages
  • Global
From
Logistics Automation - Global Strategic Business Report - Product Image

Logistics Automation - Global Strategic Business Report

  • Report
  • 209 Pages
  • Global
From
Bio-Pharmaceutical Logistics Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Bio-Pharmaceutical Logistics Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.